By emphasizing the impact of hyperglycemia on oral epithelial health, this study highlights the importance of future translational and clinical research to explore the diagnostic and therapeutic potential of targeting reduced E-cadherin in diabetes-associated oral complications. Here, CDH1 is linked to diabetes mellitus.